Computational drug repurposing strategy predicted peptide-based drugs that can potentially inhibit the interaction of SARS-CoV-2 spike protein with its target (humanACE2)

被引:25
作者
Egieyeh, Samuel [1 ]
Egieyeh, Elizabeth [2 ]
Malan, Sarel [3 ]
Christofells, Alan [4 ]
Fielding, Burtram [5 ]
机构
[1] Univ Western Cape, Sch Pharm, Pharmacol & Clin Pharm Unit, Computat Pharmacol & Cheminformat Res Grp, Cape Town, South Africa
[2] Univ Western Cape, Sch Pharm, Pharmacol & Clin Pharm Unit, Cape Town, South Africa
[3] Univ Western Cape, Sch Pharm, Pharmaceut Chem Unit, Cape Town, South Africa
[4] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Cape Town, South Africa
[5] Univ Western Cape, Dept Med Biosci, Mol Biol & Virol Res Lab, Cape Town, South Africa
来源
PLOS ONE | 2021年 / 16卷 / 01期
关键词
ACE2;
D O I
10.1371/journal.pone.0245258
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Drug repurposing for COVID-19 has several potential benefits including shorter development time, reduced costs and regulatory support for faster time to market for treatment that can alleviate the current pandemic. The current study used molecular docking, molecular dynamics and protein-protein interaction simulations to predict drugs from the Drug Bank that can bind to the SARS-CoV-2 spike protein interacting surface on the human angiotensin-converting enzyme 2 (hACE2) receptor. The study predicted a number of peptide-based drugs, including Sar9 Met (O2)11-Substance P and BV2, that might bind sufficiently to the hACE2 receptor to modulate the protein-protein interaction required for infection by the SARS-CoV-2 virus. Such drugs could be validated in vitro or in vivo as potential inhibitors of the interaction of SARS-CoV-2 spike protein with the human angiotensin-converting enzyme 2 (hACE2) in the airway. Exploration of the proposed and current pharmacological indications of the peptide drugs predicted as potential inhibitors of the interaction between the spike protein and hACE2 receptor revealed that some of the predicted peptide drugs have been investigated for the treatment of acute respiratory distress syndrome (ARDS), viral infection, inflammation and angioedema, and to stimulate the immune system, and potentiate antiviral agents against influenza virus. Furthermore, these predicted drug hits may be used as a basis to design new peptide or peptidomimetic drugs with better affinity and specificity for the hACE2 receptor that may prevent interaction between SARS-CoV-2 spike protein and hACE2 that is prerequisite to the infection by the SARS-CoV-2 virus.
引用
收藏
页数:14
相关论文
共 29 条
  • [1] Akhtar R, 2019, PAK J PHARM SCI, V32, P2215
  • [2] UniProt: a hub for protein information
    Bateman, Alex
    Martin, Maria Jesus
    O'Donovan, Claire
    Magrane, Michele
    Apweiler, Rolf
    Alpi, Emanuele
    Antunes, Ricardo
    Arganiska, Joanna
    Bely, Benoit
    Bingley, Mark
    Bonilla, Carlos
    Britto, Ramona
    Bursteinas, Borisas
    Chavali, Gayatri
    Cibrian-Uhalte, Elena
    Da Silva, Alan
    De Giorgi, Maurizio
    Dogan, Tunca
    Fazzini, Francesco
    Gane, Paul
    Cas-tro, Leyla Garcia
    Garmiri, Penelope
    Hatton-Ellis, Emma
    Hieta, Reija
    Huntley, Rachael
    Legge, Duncan
    Liu, Wudong
    Luo, Jie
    MacDougall, Alistair
    Mutowo, Prudence
    Nightin-gale, Andrew
    Orchard, Sandra
    Pichler, Klemens
    Poggioli, Diego
    Pundir, Sangya
    Pureza, Luis
    Qi, Guoying
    Rosanoff, Steven
    Saidi, Rabie
    Sawford, Tony
    Shypitsyna, Aleksandra
    Turner, Edward
    Volynkin, Vladimir
    Wardell, Tony
    Watkins, Xavier
    Zellner, Hermann
    Cowley, Andrew
    Figueira, Luis
    Li, Weizhong
    McWilliam, Hamish
    [J]. NUCLEIC ACIDS RESEARCH, 2015, 43 (D1) : D204 - D212
  • [3] Toward Small-molecule Inhibition of Protein-protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions
    Bojadzic, Damir
    Buchwald, Peter
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (08) : 674 - 699
  • [4] SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
    Daina, Antoine
    Michielin, Olivier
    Zoete, Vincent
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [5] The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
    Gorbalenya, Alexander E.
    Baker, Susan C.
    Baric, Ralph S.
    de Groot, Raoul J.
    Drosten, Christian
    Gulyaeva, Anastasia A.
    Haagmans, Bart L.
    Lauber, Chris
    Leontovich, Andrey M.
    Neuman, Benjamin W.
    Penzar, Dmitry
    Perlman, Stanley
    Poon, Leo L. M.
    Samborskiy, Dmitry V.
    Sidorov, Igor A.
    Sola, Isabel
    Ziebuhr, John
    [J]. NATURE MICROBIOLOGY, 2020, 5 (04) : 536 - 544
  • [6] Compassionate Use of Remdesivir for Patients with Severe Covid-19
    Grein, J.
    Ohmagari, N.
    Shin, D.
    Diaz, G.
    Asperges, E.
    Castagna, A.
    Feldt, T.
    Green, G.
    Green, M. L.
    Lescure, F-X
    Nicastri, E.
    Oda, R.
    Yo, K.
    Quiros-Roldan, E.
    Studemeister, A.
    Redinski, J.
    Ahmed, S.
    Bernett, J.
    Chelliah, D.
    Chen, D.
    Chihara, S.
    Cohen, S. H.
    Cunningham, J.
    Monforte, A. DArminio
    Ismail, S.
    Kato, H.
    Lapadula, G.
    L'Her, E.
    Maeno, T.
    Majumder, S.
    Massari, M.
    Mora-Rillo, M.
    Mutoh, Y.
    Nguyen, D.
    Verweij, E.
    Zoufaly, A.
    Osinusi, A. O.
    DeZure, A.
    Zhao, Y.
    Zhong, L.
    Chokkalingam, A.
    Elboudwarej, E.
    Telep, L.
    Timbs, L.
    Henne, I
    Sellers, S.
    Cao, H.
    Tan, S. K.
    Winterbourne, L.
    Desai, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (24) : 2327 - 2336
  • [7] The emerging role of ACE2 in physiology and disease
    Hamming, I.
    Cooper, M. E.
    Haagmans, B. L.
    Hooper, N. M.
    Korstanje, R.
    Osterhaus, A. D. M. E.
    Timens, W.
    Turner, A. J.
    Navis, G.
    van Goor, H.
    [J]. JOURNAL OF PATHOLOGY, 2007, 212 (01) : 1 - 11
  • [8] Molecular Dynamics Simulation for All
    Hollingsworth, Scott A.
    Dror, Ron O.
    [J]. NEURON, 2018, 99 (06) : 1129 - 1143
  • [9] MDWeb and MDMoby: an integrated web-based platform for molecular dynamics simulations
    Hospital, Adam
    Andrio, Pau
    Fenollosa, Carles
    Cicin-Sain, Damjan
    Orozco, Modesto
    Lluis Gelpi, Josep
    [J]. BIOINFORMATICS, 2012, 28 (09) : 1278 - 1279
  • [10] VMD: Visual molecular dynamics
    Humphrey, W
    Dalke, A
    Schulten, K
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1996, 14 (01) : 33 - 38